A New Combination Therapy for Scalp Alopecia Areata: An Approach to High Negative Pressure Microdermabrasion with Intralesional Steroids

    October 2021 in “ Book Publisher International (a part of SCIENCEDOMAIN International) ”
    M Iftikhar Sheikh
    TLDR The combination therapy of microdermabrasion and steroid injections is more effective for treating scalp Alopecia Areata than steroid injections alone.
    The study investigates a new combination therapy for treating scalp Alopecia Areata (AA) by using high negative pressure microdermabrasion (MD) along with intralesional steroid (ILST) injections. The results of this combination therapy were compared to the use of ILST alone. AA is an autoimmune condition affecting 0.1-0.2% of the population, leading to hair loss in otherwise healthy individuals. The study suggests that combining MD with ILST may offer a more effective treatment option compared to ILST alone, although the paper does not provide specific data on the number of participants or detailed outcomes.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community *WOMEN* on Spironolactone - experiences?

       6 upvotes 9 years ago
      Hair loss treatments discussed: Minoxidil, Finasteride, RU58841, and Spironolactone. Woman with androgenetic alopecia and alopecia areata shares experience using Spironolactone.

      community Fuck hair loss; acquire beard.

      in Shaved/buzzed  935 upvotes 2 years ago
      A user's transformation from an accountant to a spartan with a full beard, discussing the potential of DUPA and alopecia areata, as well as treatments like vitamins, topicals, and natural treatments for potential regrowth.

      community DHT and 5AR respect post, it's importance within the brain

      in Research/Science  111 upvotes 8 months ago
      The conversation discusses whether to use finasteride for hair loss, considering its role in inhibiting DHT and 5AR, which can affect brain function and mood. Some users report anxiety and depression from finasteride, while others do not experience these side effects and emphasize the importance of DHT for brain and prostate health.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  37 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community So we’re just ok with taking a research chemical now?

      in Treatment  181 upvotes 3 years ago
      The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.

    Related Research

    3 / 3 results